Isolation of a new cell population in the glioblastoma microenvironment

Journal of Neuro-Oncology

Volumn 106, Issue 3, 2012, Pages 493-504

  Clavreul, Anne ^a,b,c   Etcheverry, Amandine ^d,e,f,g   Chassevent, Agnés ^h   Quillien, Véronique ^e,f,i   Avril, Tony ⁱ   Jourdan, Marie Lise ^j,k   Michalak, Sophie ^c   François, Patrick ^k   Carré, Jean Luc ^l   Mosser, Jean ^d,e,f,g   Menei, Philippe ^a,b,c  

^a LUNAM Universite   (France)

^b INSERM   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d IFR 140   (France)

^e UNIVERSITÉ DE RENNES 1   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g RENNES UNIVERSITY HOSPITAL   (France)

^h CENTRE PAUL PAPIN   (France)

ⁱ CENTRE EUGÈNE MARQUIS   (France)

^j CHRU de Tours   (France)

^k UNIVERSITY HOSPITAL OF TOURS   (France)

^l Facult de Mdecine   (France)

more..

Author keywords

Cancer associated fibroblasts; Glioblastoma; Microenvironment; Primary cultures; Translational study

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CELL SURFACE PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TUMOR MARKER;

ARTICLE; CELL HETEROGENEITY; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; DIPLOIDY; DISEASE MARKER; FIBROBLAST; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NEUROEPITHELIUM; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIMARY CELL CULTURE; PROTEOMICS; STEREOTACTIC BIOPSY; STROMA CELL; TUMOR MICROENVIRONMENT;

BIOPSY; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RNA, MESSENGER;

EID: 84857047902     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0701-7     Document Type: Article

References (48)

1. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
2. Giese A, Kucinski T, Knopp U et al (2004) Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma. J Neurooncol 66:351-360 (Pubitemid 38258351)
3. Lefranc F, Brotchi J, Kiss R (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:2411-2422 (Pubitemid 46218735)
4. Liang BC, Thornton AF Jr, Sandler HM et al (1991) Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 75:559-563
5. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119-150
6. Ostman A, Augsten M (2009) Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev 19:67-73
7. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337 (Pubitemid 39551661)
8. Shimoda M, Mellody KT, Orimo A (2010) Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 21:19-25
9. Franco OE, Shaw AK, Strand DW et al (2010) Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21:33-39
10. Xie Z (2009) Brain tumor stem cells. Neurochem Res 34: 2055-2066
11. Chen R, Nishimura MC, Bumbaca SM et al (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17:362-375
12. Jain RK, di Tomaso E, Duda DG et al (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610-622 (Pubitemid 47093931)
13. Yang I, Han SJ, Kaur G et al (2010) The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci 17:6-10
14. Sonabend AM, Rolle CE, Lesniak MS (2008) The role of regulatory T cells in malignant glioma. Anticancer Res 28:1143-1150 (Pubitemid 351578852)
15. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109 (Pubitemid 47103521)
16. Vindelov LL, Christensen IJ, Nissen NI (1983) A detergenttrypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327 (Pubitemid 13087609)
17. Roger M, Clavreul A, Venier-Julienne MC et al (2010) Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 31:8393-8401
18. Hupe P, Stransky N, Thiery JP et al (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20:3413-3422 (Pubitemid 40136776)
19. Clavreul A, Jean I, Preisser L et al (2009) Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy. In Vitro Cell Dev Biol Anim 45:500-511
20. Glas M, Rath BH, Simon M et al (2010) Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol 68:264-269
21. Westermark B, Ponten J, Hugosson R (1973) Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol Microbiol Scand A 81:791-805
22. Rutka JT, Giblin JR, Dougherty DY et al (1987) Establishment and characterization of five cell lines derived from human malignant gliomas. Acta Neuropathol 75:92-103 (Pubitemid 18011891)
23. Gibbons HM, Hughes SM, Van Roon-Mom W et al (2007) Cellular composition of human glial cultures from adult biopsy brain tissue. J Neurosci Methods 166:89-98 (Pubitemid 47374816)
24. Orimo A, Weinberg RA (2007) Heterogeneity of stromal fibroblasts in tumors. Cancer Biol Ther 6:618-619 (Pubitemid 47328338)
25. Raica M, Cimpean AM (2010) Platelet-derived growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals 3:572-599
26. Amillet JM, Ferbus D, Real FX et al (2006) Characterization of human Rab20 overexpressed in exocrine pancreatic carcinoma. Hum Pathol 37:256-263 (Pubitemid 43277513)
27. Lee HS, Han J, Bai HJ et al (2009) Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface. FEBS J 276:4622-4635
28. Idbaih A, Carvalho Silva R, Criniere E et al (2008) Genomic changes in progression of low-grade gliomas. J Neurooncol 90: 133-140
29. van Agthoven T, Sieuwerts AM, Meijer-van Gelder ME et al (2009) Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. J Clin Oncol 27:542-549
30. Blaschuk OW, Devemy E (2009) Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 625:195-198
31. Krishna K, Redies C (2009) Expression of cadherin superfamily genes in brain vascular development. J Cereb Blood Flow Metab 29:224-229
32. Teodorczyk M, Martin-Villalba A (2009) Sensing invasion: cell surface receptors driving spreading of glioblastoma. J Cell Physiol 222:1-10
33. Hayward SW, Wang Y, Cao M et al (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 61:8135-8142 (Pubitemid 33091604)
34. Orimo A, Gupta PB, Sgroi DC et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348 (Pubitemid 40692295)
35. Gonda TA, Varro A, Wang TC et al (2010) Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anticancer therapy? Semin Cell Dev Biol 21:2-10
36. Bauchet L, Mathieu-Daude H, Fabbro-Peray P et al (2010) Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol
37. Pietras K, Ostman A (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316:1324-1331
38. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265-273
39. Phillips HS, Kharbanda S, Chen R et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173 (Pubitemid 43357943)
40. Tso CL, Shintaku P, Chen J et al (2006) Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 4:607-619 (Pubitemid 44497214)
41. Ricci-Vitiani L, Pallini R, Larocca LM et al (2008) Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ 15: 1491-1498
42. Gunther HS, Schmidt NO, Phillips HS et al (2008) Glioblastomaderived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27: 2897-2909 (Pubitemid 351620450)
43. Rieske P, Golanska E, Zakrzewska M et al (2009) Arrested neural and advanced mesenchymal differentiation of glioblastoma cellscomparative study with neural progenitors. BMC Cancer 9:54
44. Carro MS, Lim WK, Alvarez MJ et al (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318-325
45. Nakamizo A, Marini F, Amano T et al (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318 (Pubitemid 40524615)
46. Nakamura K, Ito Y, Kawano Y et al (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155-1164 (Pubitemid 39117311)
47. Kang SG, Shinojima N, Hossain A et al (2010) Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 67:711-720
48. Mishra PJ, Humeniuk R, Medina DJ et al (2008) Carcinomaassociated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68:4331-4339